Supernus Prices Offering of $75 Million of 7.50% Convertible Senior Secured Notes Due 2019 Read more about Supernus Prices Offering of $75 Million of 7.50% Convertible Senior Secured Notes Due 2019
Supernus Announces Proposed Offering of $75 Million of Convertible Senior Secured Notes Read more about Supernus Announces Proposed Offering of $75 Million of Convertible Senior Secured Notes
Indevus Announces FDA Approval of Sanctura® XR Read more about Indevus Announces FDA Approval of Sanctura® XR
Supernus Pharmaceuticals Announces Significant Progress with Partnership Products Read more about Supernus Pharmaceuticals Announces Significant Progress with Partnership Products
Supernus Pharmaceuticals Announces Second Closing Raising an Additional $17.5 Million Read more about Supernus Pharmaceuticals Announces Second Closing Raising an Additional $17.5 Million
Indevus Announces Allergan as New Partner for Sanctura® Brand Read more about Indevus Announces Allergan as New Partner for Sanctura® Brand
Supernus Pharmaceuticals Acquires Drug Formulation Business of Shire Laboratories Inc. Read more about Supernus Pharmaceuticals Acquires Drug Formulation Business of Shire Laboratories Inc.
Supernus Pharmaceuticals Announces Partnership with United Therapeutics Read more about Supernus Pharmaceuticals Announces Partnership with United Therapeutics
Supernus Pharmaceuticals Reports Fourth Quarter 2012 and Full Year 2012 Financial Results Read more about Supernus Pharmaceuticals Reports Fourth Quarter 2012 and Full Year 2012 Financial Results
Supernus Announces Year-End and Fourth Quarter 2012 Earnings Conference Call and Webcast Read more about Supernus Announces Year-End and Fourth Quarter 2012 Earnings Conference Call and Webcast